Whole genome sequencing of an ethnic Pathan (Pakhtun) from the north-west of Pakistan by Ilyas, Muhammad et al.
Ilyas et al. BMC Genomics  (2015) 16:172 
DOI 10.1186/s12864-015-1290-1RESEARCH ARTICLE Open AccessWhole genome sequencing of an ethnic Pathan
(Pakhtun) from the north-west of Pakistan
Muhammad Ilyas1,2, Jong-Soo Kim3, Jesse Cooper3, Young-Ah Shin3, Hak-Min Kim2,4, Yun Sung Cho2,4,
Seungwoo Hwang5, Hyunho Kim4, Jaewoo Moon3, Oksung Chung2, JeHoon Jun2, Achal Rastogi2,
Sanghoon Song3, Junsu Ko3, Andrea Manica6*, Ziaur Rahman1*, Tayyab Husnain1 and Jong Bhak2,3,4*Abstract
Background: Pakistan covers a key geographic area in human history, being both part of the Indus River region that
acted as one of the cradles of civilization and as a link between Western Eurasia and Eastern Asia. This region is
inhabited by a number of distinct ethnic groups, the largest being the Punjabi, Pathan (Pakhtuns), Sindhi, and Baloch.
Results: We analyzed the first ethnic male Pathan genome by sequencing it to 29.7-fold coverage using the Illumina
HiSeq2000 platform. A total of 3.8 million single nucleotide variations (SNVs) and 0.5 million small indels were identified
by comparing with the human reference genome. Among the SNVs, 129,441 were novel, and 10,315 nonsynonymous
SNVs were found in 5,344 genes. SNVs were annotated for health consequences and high risk diseases, as well as
possible influences on drug efficacy. We confirmed that the Pathan genome presented here is representative of this
ethnic group by comparing it to a panel of Central Asians from the HGDP-CEPH panels typed for ~650 k SNPs. The
mtDNA (H2) and Y haplogroup (L1) of this individual were also typical of his geographic region of origin. Finally, we
reconstruct the demographic history by PSMC, which highlights a recent increase in effective population size
compatible with admixture between European and Asian lineages expected in this geographic region.
Conclusions: We present a whole-genome sequence and analyses of an ethnic Pathan from the north-west province of
Pakistan. It is a useful resource to understand genetic variation and human migration across the whole Asian continent.Background
Sequencing technology is improving fast, with a drastic
reduction of its costs [1]. These rapid advances have
greatly expanded our understanding of human genetic
diversity and population history [2], enabling us to inves-
tigate variants with health consequences and paving the
way to personalized medicine [3]. Genome wide associ-
ation studies (GWAS) have characterized the function of
thousands of common SNVs, but there are still millions
of variants left unexplored [4]. Therefore, whole genome
sequencing is necessary for a detailed study of rare gen-
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unless otherwise stated.started sequencing the whole genomes of large panels,
including the 1000 Genomes Project (www.1000
genomes.org), the Personal Genome Project (www.
personalgenomes.org), and the 100 Malay genomes [5].
These consortia, as well as several geographically more re-
stricted projects, aim to understand the functional aspects
of both common and unique variants in humans. In the fu-
ture, we can expect all distinct ethnic groups to have their
genomes sequenced.
Pakistan lies at a junction of the Indian sub-continent
in the East, the Central Asian States in the West, and
China towards its North. It has a unique socio-religious-
cultural history, in addition to a number of ethnic and
linguistic groups such as Punjabi, Pathan (Pakhtuns),
Sindhi, and Baloch (Additional file 1: Figure S1) [6].
While a number of these groups have been included in
genetic panels typing microsatellites and SNPs [7], only
one male Pakistani individual of unknown ethnic origin
has been sequenced so far (Additional file 1: Figure S2)
[8]. Here we report the first whole-genome sequenceis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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omic variations including single nucleotide variations
(SNVs), small insertions and deletions (indels), and copy
number variation regions (CNVRs) were identified by
aligning the Pathan genome sequence to the Human
Reference Genome (hg19). Variants were then annotated
and scanned for associated functions along with SNVs
that could modulate drug response. Possible deleterious
non-synonymous SNVs (nsSNVs) were investigated for
potential effect on the pharmacokinetics and pharmaco-
dynamics of drugs. Additionally, multiple analytical ap-
proaches were used to assess the influence of ancestral
contributions within the Pathan (PTN) genome.Results and discussion
Genome sequencing and variants identification
DNA extracted from blood was sequenced with paired-
end reads of 90 bp using the Illumina HiSeq2000 se-
quencer, producing 1,069,127,687 reads. A total of 83.3
Gb of sequences were generated and aligned to the hu-
man reference genome (without Ns, 2,861,343,702 bp),
covering 98.2% of the reference genome at an average
28.5× depth (Additional file 2: Table S1).
We identified a total of 3,813,440 SNVs, of which
3,683,999 (96.6%) were reported in the dbSNP database
[9] and 129,441 were novel (Table 1) which were fur-
ther compared with the novel variants count of other
individual genomes from literature (Additional file 1:
Figure S3) [10-19]. There were 1,272,912 homozygous
and 2,540,528 heterozygous SNVs. A total of 18,547
SNVs were found in coding DNA sequence (CDS) re-
gions, 25,481 in 3’ untranslated regions (UTR), and
4,969 in 5’ UTRs. A total of 10,315 SNVs in 5,344 genes
were non-synonymous (nsSNVs).
A total of 504,276 short indels (up to ±20 bases) were
observed, of which 306,128 were found in intergenic re-
gions, 237 in CDS regions, and 193,308 in intron re-
gions. Additionally, 1,503 CNVRs were found, 713 of
which were classed as duplicated and 790 as deleted, af-
fecting 2,364 overlapped genes (Additional file 3: Table
S2). A total of 65 CNVRs had not previously been de-
scribed in the database of genomic variants (DGV;
http://projects.tcag.ca/variation/). Figure 1 shows the
number of gained and lost CNVRs in each chromosome.
ANNOVAR was used for detailed annotation analysis of
CNVRs to identify genes associated with these regions
(Additional file 4: Table S3).Table 1 Summary of SNVs found in Pathan’s genome and ove
Total Homozygous Heterozygous SNVs map
to dbSNPSNVs SNVs SNVs
3,813,440 1,272,912 2,540,528 3,683,999Functional classification and clinical relevance of variants
All 10,315 nsSNVs found in the Pathan genome were fur-
ther scrutinized for their possible functional effects using
computational prediction methods (SIFT and Polyphen2),
resulting in 43 nsSNVs in 43 genes being classified as
functionally damaging (Additional file 5: Table S4). Add-
itionally, nsSNVs were annotated using ClinVar for their
clinical relevance, and we found that 31 coding SNVs are
associated with several diseases (Additional file 6: Table
S5). Of particular note are an SNV (rs1049296, Pro570Ser)
in the TF gene [20], which affects Alzheimer’s susceptibil-
ity; Ser217Leu in ELAC2 gene (rs4792311), which is impli-
cated in genetic susceptibility to hereditary prostate
cancer [21]. The rate of prostate cancer is low in Pakistan
(3.8%) [22], as compare to Americans and Caucasian [23].
Three coding SNVs on GHRLOS (rs696217, Leu72Met),
SERPINE1 (rs6092, Ala15Thr), and PPARG (rs1801282,
Pro12Ala) which all have links with obesity [24-26].
About 22.2% of Pakistanis are reported to be obese
which is close to European (~24%) and United States
populations (~19%) [27-29].
We also found three pathogenic SNVs in genes associ-
ated with hair, skin and pigmentation: EDAR (rs3827760,
Val370Ala), SLC45A2 (rs16891982, Phe374Leu), and TYR
(rs1042602, Ser192Tyr) [30-32]. In addition, we detected a
SNV (rs17822931, Gly180Arg) in ABCC11, which is re-
sponsible for wet earwax which was also found in the
Pakistani PK1 genome [33].
One of the variants (rs1065852, Pro34Ser) in the
CYP2D6 gene is responsible for poor metabolism of debri-
soquine, an adrenergic-blocking medication used for the
treatment of hypertension [34]. Also, two SNVs in the
TPMT (rs1142345, Tyr240Cys and rs1800460, Ala154Thr)
are known to have a pathogenic effect and lead to thio-
purine methyltransferase (TPMT) deficiency [35,36].
Moreover two nsSNVs (rs2056899 and rs140980900) of
CYP4A22 and GGT5 genes in the Arachidonic acid me-
tabolism pathway were found (Additional file 7: Table
S6). Arachidonic acid in the human body usually comes
from dietary animal sources, such as meat, eggs, and
dairy. Meat is an important part of a Pathan’s diet, usu-
ally consumed at least once a day, often in the form of
kabab (minced meat fried in oil), or curry [37].
Comparative genomic analysis was done using Pathan
(PTN) genome and the other previously published
Pakistani (PK1) genome. Non-synonymous variants
from Pakistani (PK1) genome were annotated for inves-
tigating associated diseases. Out of ~8,000 nsSNVs onlyrlaps with dbSNP137
ped
(v137)
% of SNVs
mapped to dbSNP
Novel % of Novel
SNVs SNVs
96.6% 129,441 3.39%
Figure 1 Copy number variation regions in Pathan genome. Copy number variations counts distributed in each chromosome.
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disorders. Eight clinically relevant SNVs were detected
overlapped with Pathan (PTN) genome. We found no
damaged variants responsible for Alzheimer’s, obesity
and heart related diseases just like we found in Pathan
(PTN) genome. An SNV (rs1057910; CYP2C9) was ob-
served in PK1 genome which is known for Wafarin re-
sponse. Moreover, a pathogenic mutation (rs1169305)
was seen in the HNF1A gene which may become a
cause of diabetes in the PK1 individual.
Most of the clinically relevant variants adopted in this
study were originally described in Caucasian popula-
tions. While this result might be a consequence of the
genomic affinities of the Pathan genome with other
Caucasian populations, it might also reflect a bias due to
most of the GWAS work being carried out on Caucasian
populations [38]. Therefore a cohort study in the Pakistani
population will be required for authentication.
Pharmacogenomics analysis
Damaging nsSNVs were annotated using PharmGKB
and DrugBank databases [39,40]. A large number of var-
iants were associated with susceptibility to poisonous
drugs, while others nsSNV were linked to the efficacy of
medicines used in the treatment of diseases such as de-
pression, diabetes mellitus, Alzheimer disease, arthritis
and so on (Additional file 8: Table S7). After discoveringthe possibly damaged variants found in SIFT and Poly-
phen2, the consensus of both datasets was further ana-
lyzed in order to find the most probable impact of these
deleterious variants in terms of drug targeting, transport,
and metabolism. We found nsSNVs that affect the func-
tion of drugs (two transport, five enzymatic, and four
drug targets). A variant rs1801133 (A222V in MTHFR
gene) was found associated with increased risk of meta-
bolic syndrome when treated with antipsychotics [41].
Our donor has high chance of having decreased diastolic
blood pressure if treated with benazepril [42]. One of
the variants (rs1799930, R197Q in NAT2 gene) was asso-
ciated with increased risk of toxic liver disease when
treated with ethambutol, isoniazid, pyrazinamide, and ri-
fampin [43]. We also observed an SNV (rs1065852,
Chr22:42526694 G > A) which made this individual use
escitalopram for depression and other anxiety [44]. The
detail list of those drugs can be found in Additional file
9: Table S8.
Comparison with other Pathan individuals
We investigated how representative our Pathan genome
was of that ethnic group by comparing it to another
twenty-two Pathan individuals in the HGDP-CEPH
panel [7], which had been typed for ~650 k SNVs, to-
gether with a further 190 individuals from another eight
South Asian (Pakistani) populations from the same panel.
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SNVs (thinned to avoid LD). We considered the cluster
membership from STRUCTURE (from K = 2 to K = 5),
the Pathan (PTN) genome composition was within the
variability observed within the Pathan sample from the
HGDP (Figure 2). Similarly, in a multi-dimensional
scaling (MDS) plot, the Pathan genome fell within the
other Pathan individuals (Additional file 1: Figure S4).
Taken together, these two results confirm that the Pathan
genome presented in this paper is representative of the
Pathan ethnic group. These results are also in line with
the self-reported ancestry of the subject, with all his
grandparents coming from Afghanistan to Khyber
Pakhtunkhwa (Pakistan).Figure 2 Admixture results of Pathan (PTN) individual to other ethnic g
Pathan individual combined with eight ethnic genomes from HGDP dataset.
by a vertical line, divided into colored segments that represent membership cmtDNA and Y-chromosome analyses
The full mitochondrial genome of the Pathan individual
was generated by mapping its reads to the revised
Cambridge reference sequence (rCRS) [45]. Adenine and
thymine (AT) content of the genome was 55.5%, while
guanine and cytosine (GC) content was 44.5%. A total of
57 SNVs were found in the Pathan mitochondrial genome,
13 of which had not been previously reported. The vari-
ants were then mapped with MitoVariome [46] to identify
the mitochondrial haplogroup of our Pathan individual. A
total of 14 SNVs were diagnostic of the H2 haplogroup
(Additional file 10: Table S9), which has been argued to be
of exclusive Caucasian origin, and its marginal occurrence
in Pathans reflects admixture [47].roups in South Asia. Admixture results for K = 2 and K = 5 for the
The analysis was based on 643,281 SNVs. Each individual is represented
oefficients in the subgroups.
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39.87% and 60.13%, respectively. A total of 13,724 SNVs
were identified, of which 4,423 were novel. The observed
Y-chromosomal SNVs were annotated as markers for the
L1 haplotype of clade L. Haplogroup L has high fre-
quency in Pakistan (14%) as compare to India (6.3%),
Turkey (~4%) and Caucasians (~6%) [48-50].
Demographic history analysis
We inferred the demographic history of the Pathan
using the pairwise sequentially Markovian coalescent
(PSMC) model [51] (Figure 3), and compared it to a
panel of worldwide populations based on a number of
HGDP genomes [52]. As previously reported, all popula-
tions share a similar demographic history between 1 mil-
lion to 200kyr ago. From 200kyr ago to 20kyr ago, the
Pathan follow a similar trajectory to other Asian and
European populations, with an inferred effective popu-
lation size smaller than African populations, reflecting
the out of Africa bottleneck. Over the last 20 k years,
the Pathan shows an explosion in effective population
size, contemporaneous to other Eurasian populations
but much greater in magnitude. The very large effective
population size likely reflects admixture between
European and Asian lineages giving rise to modern
Pathans (as also suggested by the analysis of mtDNA
and Y-chromosome), rather than an actual increase in
census sizes.
Conclusions
Here we present, for the first time, the whole genome of
a Pathan individual from a north-west province (Khyber
Pakhtunkhwa) of Pakistan. Our analysis provides a de-
tailed view of the Pathan genome diversity and functionalFigure 3 Inferred historical population sizes by Pairwise Sequential Ma
Coalescent) analysis was performed to reconstruct the demographic populati
around the world (Africa: Dinka, Yoruba, Mandenka, Mbuti, San; Asia: Dai, Hanclassification of variants and its impact in pharmacogen-
omics. A large scale analysis of diverse genomes is needed
to help researchers around the world in understanding
genetic diversity and functional classification of variants
along with pharmacogenomic traits and associated drugs
that would be use as personalized medicine.
Methods
Subject selection and ethical statement
This study has been performed in accordance with Dec-
laration of Helsinki and has been approved by the Insti-
tutional Review Board Genome Research Foundation
(GRF) with IRB-REC-2011-10-003. Signed informed
consents were obtained from the participant in this
study and his family members' consent on publishing
the entire content of the genome and phenotype infor-
mation, as well as personal identifying information (such
as age, sex and location).
There are documented cases of his family members
with hypertension, heart problems, neuro disorders, dia-
betes and obesity. His father has been diagnosed for car-
diovascular disorder, hypertension and Alzheimer’s. His
mother has osteoarthritis and grandparents were died
due to heart attack, cancer and hypertension.
Data sources
The UCSC reference genome (hg19, February 2009),
dbSNP version 137 and genome annotations, were
downloaded from the database (www.genome.ucsc.edu).
Genomes from HGDP-CEPH panel of 190 individuals
belong to eight South Asian (Balochi, Brahui, Burusho,
Hazara, Kalash, Makrani, Pathan and Sindhi) populations,
which had been typed for ~650 k SNVs were retrieved
from the publically available database.rkovian Coalescent analysis. PSMC (Pairwise Sequentially Markovian
on history of Pathans, compared with a set of 11 HGDP genomes from
; Europe: French, Sardinian; Oceania: Papuan; Americas: Karitiana).
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Genomic DNA was extracted from the arterial blood lym-
phocytes of a Pakistani Pathan thirty-year-old male resid-
ing in the North-West province of Pakistan. QIAamp
DNA Blood Mini Kit was used for DNA extraction from
the blood (Qiagen). Tecan’s Infinite F200 nanodrop was
used to assess DNA purity, 1.7 % agarose gel electrophor-
esis to confirm DNA size (presence of high molecular
weight DNA) and Invitrogen’s Qubit fluorometer to deter-
mine the DNA concentration.Cytogenetic analysis
Karyotyping was carried out with cultured peripheral
blood lymphocytes using standard techniques, and GTG
banding was used to identify chromosomal aberrations,
which is useful for identifying genetic diseases through
the photographic representation of the entire chromo-
some complement [53]. No obvious chromosomal ab-
normalities were found in the cytogenetic analysis
through G-banded karyotyping chromosome imaging
(Additional file 1: Figure S5).Library preparation and whole genome sequencing
Two paired-end libraries were prepared from 1.1 μg of
gDNA using Illumina TruSeq DNA Preparation Kit, fol-
lowing Illumina’s standard protocol (Paired-end Library
Preparation Kit, Illumina, SanDiego, CA, USA). Shearing
of gDNA was done using Covaris S series (Covaris, MS,
USA). Following end repair, A-tailing, and adaptor
ligation, DNA in the 500–600 bp range was purified
from a 2% agarose gel. DNA was then PCR enriched for
a total of ten cycles. Proper DNA size was then con-
firmed with the Agilent Bioanalyzer, followed by qPCR
quantification with Roche Light Cycler 480 II and Kapa
Biosystems reagents.
Cluster generation was performed on an Illumina cBot
and the libraries were sequenced on an Illumina HiSeq
2000 following the Paired-End protocol. Sequences can
be accessed at NCBI SRA, with accession number
SRA092047. The rest of our analysis was initiated from
the FASTQ files provided by Illumina's downstream ana-
lysis CASAVA software suite.Mapping and alignment to the reference genome
The genome sequences were aligned with the human ref-
erence genome (hg19) using Burrows-Wheeler Aligner
(BWA; version 0.5.9) [54] and SAMtools 0.1.16 [55] with
the default options, except “aln -t 3 -l 45 -k 2” options.
Alignment files were then merged into a single BAM file,
marked for duplicates using Picard 1.59 (http://picard.
sourceforge.net) and base quality scores were recalibrated
using Genome Analysis Toolkit (GATK v1.4) [56].SNVs, short indels, and CNVs calling
SNVs and small indels ranging from 1 to 20 bases
were identified using Genome Analysis Toolkit (GATK
v1.4) with HARD_TO_VALIDATE: MQ0 ≥ 4 and
((MQ0/(1.0 × DP)) > 0.1), 2) QualFilter = QUAL < 10,
3) DepthFilter = DP < 5 or DP < 200 options. All SNVs
were further characterized based on zygosity predic-
tions from BWA consensus model. ReadDepth 0.9.7
was used for identification of copy number variations
with bin size 0.01 [57]. Copy number calls smaller
than 1.3 were taken as loss and greater than 2.6 as
gains. The minimum size taken was 1,000 bp. All the
found variants were then further annotated in OMIM
(www.omim.org), DGV (http://projects.tcag.ca/variation/),
SIFT [58], PolyPhen2 [59], and ClinVar [60] using
ANNOVAR [61].
Results from SIFT and PolyPhen2 were compared and
common possibly damaged variants were retrieved. Non-
synonymous SNVs with functional abnormality from
Pathan genome were then annotated against publically
available datasets like DrugBank and PharmGKB to in-
vestigate association with drugs involved in different ac-
tivities which includes the list of genes/variants involved
in drug transport, metabolism and drug targets [39,40].
The methodology used for pharmacogenomic analysis
has been previously reported [62].
Multidimensional scaling and admixture analysis
To test the representativeness of the Pathan (PTN) gen-
ome, we compared it other Pathan individuals that had
been typed for ~650 k SNPs in the HGDP-CEPH panel,
together with individuals from another eight Central
Asian populations. We use multi-dimensional scaling to
visualize the relationships among all this individuals,
using 643,281 SNVs thinned using PLINK (50 basepair
sliding windows, advancing in steps of 10, removing any
SNV with R2 bigger than 0.1 with any other SNV within
the same window). MDS components were obtained
using the PLINK mds-plot option based on the identity-
by-state (IBS) distance matrix. Admixture analysis was
performed using the program STRUCTURE to identify
the presence of diverse ancestral relation of the Pathan
(PTN) genome with others [63]. We explored values of
K from 2 to 5, and chose the K value that gave the low-
est cross-validation error.
Pairwise sequentially markovian coalescent analysis
We conducted a PSMC (Pairwise Sequentially Markovian
Coalescent) analysis to reconstruct the demographic
population history of Pathans [51]. We compared the
Pathan genome to a set of 11 HGDP genomes from
around the world (as published by Meyer et al.) [52].
We first used samtools to extract the diploid genomes
from their BAM files aligned to hg19, and excluded sex
Ilyas et al. BMC Genomics  (2015) 16:172 Page 7 of 8chromosomes and mitochondrial genomes because they
are haploid. In PSMC, we used the command line op-
tions -N25 -t15 -r5 -p "4 + 25*2 + 4 + 6" that have been
successfully used in previous similar analyses of human
and great apes [64].
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